Autopsy report · NCT00844480

Efficacy and Safety of Zoledronic Acid in Acute Spinal Cord Injury: Prevention of Bone Loss

“difficulty in enrollment”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 year 1 month before it started.
• Ran for about 5 years 10 months before it stopped.
• 17 participants enrolled.
• Results were posted on the registry 1 year 4 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Thomas J. Schnitzer

Sponsor type

University, hospital or other

Conditions

Bone Loss

Interventions

zoledronic acid; placebo

Participants

17

Sites

1

Countries

United States

Trials that died the same way

• Effectiveness and Safety of Spondylitis Related to Inflammatory Bowel Disease
  “Difficulty with enrollment” (98% match in meaning)
• Maintenance Dosing of Vitamin D in Crohn's Disease
  “Difficulties with enrollment” (97% match in meaning)
• Multicentric Study Comparison Between Erythropoietin and Erythropoietin Associated to Differentiating Therapy With Acid 13-cis-retinoic and Dihydroxyvitamin D3 in Myelodysplastic Syndromes Without Excess of Blasts
  “Difficulties of enrollment” (96% match in meaning)
• Extended Treatment With Vancomycin for Clostridium Difficile Colitis
  “Difficult enrollment” (95% match in meaning)
• Clinical Trial With Mesalamine 1g Suppositories
  “Enrollment difficulties” (95% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.